Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in never or light former smokers with advanced lung adenocarinoma: CALGB 30406 Meeting Abstract


Authors: Janne, P. A.; Wang, X. F.; Socinski, M. A.; Crawford, J.; Capelletti, M.; Edelman, M. J.; Villalona-Calero, M. A.; Kratzke, R. A.; Vokes, E. E.; Miller, V. A.
Abstract Title: Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in never or light former smokers with advanced lung adenocarinoma: CALGB 30406
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 539s
Language: English
ACCESSION: WOS:000208852004643
DOI: 10.1200/jco.2010.28.15_suppl.7503
PROVIDER: wos
Notes: Meeting Abstract: 7503 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vincent Miller
    270 Miller